Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01655225
Title A Study of LY3023414 in Participants With Advanced Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

Advanced Solid Tumor

lymphoma

Therapies

LY3023414 + Midazolam

Letrozole + LY3023414

LY3023414

Age Groups: adult
Covered Countries USA | ITA


No variant requirements are available.